Evegrease subcutaneous injection 250 mg syringe contains Lebrikizumab, a humanized monoclonal antibody (YJ code: 4490410G1025, 250mg 2mL 1 tube). Manufactured by Eli Lilly Japan, it is used for the treatment of moderate-to-severe atopic dermatitis by inhibiting interleukin-13 (IL-13) signaling.
Evegrease subcutaneous injection 250 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →